| Ki67 is a promising molecular target in the diagnosis of cancer LT Li, G Jiang, Q Chen, JN Zheng Molecular medicine reports 11 (3), 1566-1572, 2015 | 881 | 2015 |
| Turning cold into hot: firing up the tumor microenvironment Q Duan, H Zhang, J Zheng, L Zhang Trends in cancer 6 (7), 605-618, 2020 | 698 | 2020 |
| Translation and functional roles of circular RNAs in human cancer M Lei, G Zheng, Q Ning, J Zheng, D Dong Molecular cancer 19, 1-9, 2020 | 529 | 2020 |
| Aurora kinases: novel therapy targets in cancers A Tang, K Gao, L Chu, R Zhang, J Yang, J Zheng Oncotarget 8 (14), 23937, 2017 | 342 | 2017 |
| A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial Z Yan, J Cao, H Cheng, J Qiao, H Zhang, Y Wang, M Shi, J Lan, X Fei, ... The Lancet Haematology 6 (10), e521-e529, 2019 | 275 | 2019 |
| Ki67 targeted strategies for cancer therapy C Yang, J Zhang, M Ding, K Xu, L Li, L Mao, J Zheng Clinical and Translational Oncology 20 (5), 570-575, 2018 | 224 | 2018 |
| DNA damage response–a double-edged sword in cancer prevention and cancer therapy H Tian, Z Gao, HZ Li, BF Zhang, G Wang, Q Zhang, DS Pei, JN Zheng Cancer letters 358 (1), 8-16, 2015 | 211 | 2015 |
| Regulation of p53: a collaboration between Mdm2 and Mdmx D Pei, Y Zhang, J Zheng Oncotarget 3 (3), 228, 2012 | 179 | 2012 |
| Potent anti‐leukemia activities of humanized CD19‐targeted Chimeric antigen receptor T (CAR‐T) cells in patients with relapsed/refractory acute lymphoblastic leukemia J Cao, G Wang, H Cheng, C Wei, K Qi, W Sang, LI Zhenyu, M Shi, H Li, ... American journal of hematology 93 (7), 851-858, 2018 | 171 | 2018 |
| Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment W Zhang, Y Ge, Q Cheng, Q Zhang, L Fang, J Zheng Oncotarget 9 (4), 5480, 2018 | 167 | 2018 |
| LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification P Hou, S Meng, M Li, T Lin, S Chu, Z Li, J Zheng, Y Gu, J Bai Journal of Experimental & Clinical Cancer Research 40, 1-18, 2021 | 132 | 2021 |
| BRG1 is a prognostic marker and potential therapeutic target in human breast cancer J Bai, P Mei, C Zhang, F Chen, C Li, Z Pan, H Liu, J Zheng PloS one 8 (3), e59772, 2013 | 131 | 2013 |
| Combination therapy with EpCAM‐CAR‐NK‐92 cells and regorafenib against human colorectal cancer models Q Zhang, H Zhang, J Ding, H Liu, H Li, H Li, M Lu, Y Miao, L Li, J Zheng Journal of immunology research 2018 (1), 4263520, 2018 | 125 | 2018 |
| Keap1: one stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL H Tian, BF Zhang, JH Di, G Jiang, FF Chen, HZ Li, LT Li, DS Pei, ... Cancer letters 325 (1), 26-34, 2012 | 124 | 2012 |
| p53-mediated autophagic regulation: A prospective strategy for cancer therapy J Tang, J Di, H Cao, J Bai, J Zheng Cancer letters 363 (2), 101-107, 2015 | 113 | 2015 |
| Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis Z Li, D Wang, J Lu, B Huang, Y Wang, M Dong, D Fan, H Li, Y Gao, P Hou, ... Cell Death & Differentiation 27 (12), 3226-3242, 2020 | 105 | 2020 |
| Rap2B promotes proliferation, migration and invasion of human breast cancer through calcium-related ERK1/2 signaling pathway J Di, H Huang, D Qu, J Tang, W Cao, Z Lu, Q Cheng, J Yang, J Bai, ... Scientific reports 5 (1), 12363, 2015 | 94 | 2015 |
| DCAF1 regulates Treg senescence via the ROS axis during immunological aging Z Guo, G Wang, B Wu, WC Chou, L Cheng, C Zhou, J Lou, D Wu, L Su, ... The Journal of clinical investigation 130 (11), 5893-5908, 2020 | 90 | 2020 |
| The emerging role of RUNX3 in cancer metastasis F Chen, X Liu, J Bai, D Pei, J Zheng Oncology reports 35 (3), 1227-1236, 2016 | 89 | 2016 |
| Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells AJ Jiang, G Jiang, LT Li, JN Zheng Molecular biology reports 42, 267-275, 2015 | 89 | 2015 |
